Brookfield life sciences spin-off ARC has secured two new leasing deals at its Oxford cluster. MiroBio, a biotech company which was born at the University of Oxford and acquired by Gilead Sciences in August last year, has signed for 9,500
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.